欧美最新另类人妖I国产成人av一区二区三区在线观看I九九热精品视频在线观看I国产精品日韩在线I激情av五月婷婷I日韩精品免费

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Xenopus laevis Barrier-to-autointegration factor A (banf1-a) CSB-YP743986XBE
CSB-EP743986XBE
CSB-BP743986XBE
CSB-MP743986XBE
CSB-EP743986XBE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus laevis Tudor domain-containing protein 7 (tdrd7), partial CSB-YP743987XBE
CSB-EP743987XBE
CSB-BP743987XBE
CSB-MP743987XBE
CSB-EP743987XBE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus laevis Protein SPT2 homolog (spty2d1), partial CSB-YP743988XBE
CSB-EP743988XBE
CSB-BP743988XBE
CSB-MP743988XBE
CSB-EP743988XBE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus laevis RNA polymerase II-associated protein 3 (rpap3), partial CSB-YP743989XBE
CSB-EP743989XBE
CSB-BP743989XBE
CSB-MP743989XBE
CSB-EP743989XBE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus laevis Protein CWC15 homolog A (cwc15-a) CSB-YP743990XBE
CSB-EP743990XBE
CSB-BP743990XBE
CSB-MP743990XBE
CSB-EP743990XBE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus laevis Charged multivesicular body protein 1a (chmp1a) CSB-YP743991XBE
CSB-EP743991XBE
CSB-BP743991XBE
CSB-MP743991XBE
CSB-EP743991XBE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Glycerol-3-phosphate acyltransferase 2, mitochondrial (GPAT2), partial CSB-YP743992HU1
CSB-EP743992HU1
CSB-BP743992HU1
CSB-MP743992HU1
CSB-EP743992HU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Calcium-binding mitochondrial carrier protein SCaMC-1 (SLC25A24), partial CSB-YP743993HU1
CSB-EP743993HU1
CSB-BP743993HU1
CSB-MP743993HU1
CSB-EP743993HU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Danio rerio Rab3 GTPase-activating protein catalytic subunit (rab3gap1), partial CSB-YP743994DIL
CSB-EP743994DIL
CSB-BP743994DIL
CSB-MP743994DIL
CSB-EP743994DIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Danio rerio Acetolactate synthase-like protein (ilvbl), partial CSB-YP743995DIL
CSB-EP743995DIL
CSB-BP743995DIL
CSB-MP743995DIL
CSB-EP743995DIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Danio rerio Mitochondrial Rho GTPase 1-A (rhot1a), partial CSB-YP743996DIL
CSB-EP743996DIL
CSB-BP743996DIL
CSB-MP743996DIL
CSB-EP743996DIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mouse Cleavage and polyadenylation specificity factor subunit 6 (Cpsf6) CSB-YP743997MO
CSB-EP743997MO
CSB-BP743997MO
CSB-MP743997MO
CSB-EP743997MO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human ATPase SWSAP1 (SWSAP1) CSB-YP743998HU
CSB-EP743998HU
CSB-BP743998HU
CSB-MP743998HU
CSB-EP743998HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus tropicalis Histone H1.0 (h1f0) CSB-YP743999XBF
CSB-EP743999XBF
CSB-BP743999XBF
CSB-MP743999XBF
CSB-EP743999XBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus tropicalis Iroquois-class homeodomain protein irx-3 (irx3) CSB-YP744000XBF
CSB-EP744000XBF
CSB-BP744000XBF
CSB-MP744000XBF
CSB-EP744000XBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus tropicalis Endoplasmic reticulum-Golgi intermediate compartment protein 3 (ergic3), partial CSB-YP744001XBF1
CSB-EP744001XBF1
CSB-BP744001XBF1
CSB-MP744001XBF1
CSB-EP744001XBF1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus tropicalis Serine/threonine-protein phosphatase PP1-gamma catalytic subunit (ppp1cc) CSB-YP744002XBF
CSB-EP744002XBF
CSB-BP744002XBF
CSB-MP744002XBF
CSB-EP744002XBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human RWD domain-containing protein 4 (RWDD4) CSB-YP744003HU
CSB-EP744003HU
CSB-BP744003HU
CSB-MP744003HU
CSB-EP744003HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Danio rerio Solute carrier family 2, facilitated glucose transporter member 12 (slc2a12), partial CSB-YP744004DIL
CSB-EP744004DIL
CSB-BP744004DIL
CSB-MP744004DIL
CSB-EP744004DIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Danio rerio DDB1- and CUL4-associated factor 10 (dcaf10), partial CSB-YP744005DIL
CSB-EP744005DIL
CSB-BP744005DIL
CSB-MP744005DIL
CSB-EP744005DIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.practicalworld.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×